Pharmacovigilance Market In-Depth Analysis, Growth Strategies and Comprehensive Forecast to 2031 | Future Market Insights
A recent market study published by FMI on the pharmacovigilance market includes global industry analysis for 2016-2020 & opportunity assessment for 2021-2031, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters of the pharmacovigilance market, growth prospects of the market are obtained with maximum precision.
Pharmacovigilance Market: Taxonomy
Phase of Drug Development
- Preclinical Studies
- Phase I
- Phase II
- Phase III
- Phase IV
Type of Methods
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
Service Type Provider
- In-house Pharmacovigilance
- Contract Outsourcing
- North America
- Latin America
- Middle East & Africa
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1107
Chapter 01 – Introduction
The report begins with a detailed description of the market, followed by a detailed research methodology, providing insights on the primary as well as secondary sources referred to during the course of the study. Furthermore, it also provides an overview of the market’s key segments.
Chapter 02 – Executive Summary
This section provides an executive summary of the pharmacovigilance market, which includes a summary of key findings and statistics of the market. It also includes the demand-side & supply-side trends about the pharmacovigilance market.
Chapter 03 – Pharmacovigilance Market Dynamics
This chapter begins by providing a detailed taxonomy in the form of segments. This chapter explains key macro-economic factors that are expected to influence the growth of the pharmacovigilance market over the forecast period. Along with the macroeconomic factors, this section also highlights the value chain and forecast factors for the pharmacovigilance market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided.
Chapter 04 – Global Pharmacovigilance Market Analysis by Phase of Drug Development
Based on phase of drug development, the pharmacovigilance market is segmented into preclinical studies, phase I, phase II, phase III and phase IV. In this chapter, readers can find information about the key trends and developments in the pharmacovigilance market and market attractiveness analysis based on phase of drug development.
Chapter 05 – Global Pharmacovigilance Market Analysis by Type of Methods
Based on type of methods, the pharmacovigilance market is segmented into spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event reporting and EHR mining. In this chapter, readers can find information about the key trends and developments in the pharmacovigilance market and market attractiveness analysis based on type of methods.
Chapter 06 – Global Pharmacovigilance Market Analysis by Service Type Provider
Based on service type provider, the pharmacovigilance market is segmented into in-house pharmacovigilance and contract outsourcing. In this chapter, readers can find information about the key trends and developments in the pharmacovigilance market and market attractiveness analysis based on service type provider.
Chapter 07 – Global Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031, by Geography
This chapter explains how the pharmacovigilance market will grow across several geographic regions such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Chapter 08 – North America Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter includes a detailed analysis of the growth of the North America pharmacovigilance market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on end use and countries in North America.
Chapter 09 – Latin America Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter provides the growth scenario of the pharmacovigilance market in Latin American countries such as Brazil, Mexico and the Rest of Latin America. Along with this, an assessment of the market across target segments has been provided.
Chapter 10 – Europe Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
Important growth prospects of the pharmacovigilance market based on its end use in several countries such as Germany, U.K., France, Spain, Italy, Russia and Rest of Europe are included in this chapter.
Chapter 11 – Asia Pacific Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
Important growth prospects of the pharmacovigilance market based on its end use in several countries such as China, India, ASEAN, Japan and Rest of Asia-Pacific are included in this chapter.
Chapter 12 – Middle East & Africa Pharmacovigilance Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter highlights the growth of the pharmacovigilance market in Middle East & Africa by focusing on GCC countries, South Africa and Rest of MEA. This section also helps readers understand the key factors that are responsible for the growth of the pharmacovigilance market in Middle East and Africa.
Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-1107
Chapter 13 – Global Pharmacovigilance Market Recommendations
In this chapter, reader can glean information about recommendations concerning key market strategies implementation. This section incorporates an in-depth discussion on strategic partnerships and collaborations with CROs and life sciences BPOs, optimization of drug safety through Hub and Spoke model, developing operation activities for better outcomes and regional expansion.
Chapter 14 – Global Pharmacovigilance Market Company Profiles
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the pharmacovigilance market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Accenture Plc., Bristol-Myers Squibb, Clinquest Group B.V., Cognizant Technology Solutions, Covance Inc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc., ICON Plc, iGATE Corporation, iMED Global Corporation, inVentiv Health Inc., Novartis AG, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development LLC. (PPD), PRA Health Sciences Inc., Quintiles Transnational Holdings Inc., Sanofi SA, Synowledge LLC and Wipro Ltd. among others.
Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.
Microbial Therapeutic Products Market – The global microbial therapeutic products market is poised to expand robustly at a value CAGR worth 7% across the 2020-2030 assessment period. Rising prevalence of lifestyle induced chronic disorders as well as antimicrobial resistance are primarily driving the market’s growth.
Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals, independent catheterization centers, and healthcare clinics will continue rising. Spurred by this, the global transradial closure devices market is set to grow by 6.5% CAGR during the forecast period from the year 2020 to 2030.
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org